Jianlei Hao Selected Research

Jianlei Hao Research Topics

Disease

16	Neoplasms (Cancer) 02/2024 - 07/2010
4	Inflammation (Inflammations) 01/2023 - 11/2010
2	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2021
2	Fibrosis (Cirrhosis) 01/2022 - 08/2014
2	Autoimmune Diseases (Autoimmune Disease) 12/2021 - 07/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020 - 01/2020
2	Wounds and Injuries (Trauma) 01/2018 - 01/2017
2	Experimental Arthritis 09/2012 - 01/2011
2	Arthritis (Polyarthritis) 09/2012 - 01/2011
1	Melanoma (Melanoma, Malignant) 03/2024
1	Virus Diseases (Viral Diseases) 02/2024
1	Hepatocellular Carcinoma (Hepatoma) 01/2023
1	Bites and Stings (Sting) 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Hyperplasia 10/2020
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2020
1	Obesity 01/2020
1	Non-alcoholic Fatty Liver Disease 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 09/2019
1	Spinal Cord Injuries (Spinal Cord Injury) 08/2019
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2014
1	Hypertension (High Blood Pressure) 08/2014
1	Multiple Sclerosis 06/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2014
1	Experimental Melanoma 07/2013
1	Fibrosarcoma 07/2013
1	Infections 07/2013
1	Pain (Aches) 02/2013
1	Breakthrough Pain 02/2013
1	Rheumatoid Arthritis 09/2012
1	Hepatitis 11/2011
1	Massive Hepatic Necrosis 11/2011
1	Communicable Diseases (Infectious Diseases) 11/2010

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2020 - 11/2010
4	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2020
4	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2020
4	Interleukin-17 (Interleukin 17)IBA 01/2018 - 11/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 01/2022 - 01/2020
2	ButyrophilinsIBA 12/2021 - 01/2020
2	tylophorineIBA 09/2019 - 09/2012
2	Interleukin-6 (Interleukin 6)IBA 11/2014 - 08/2014
1	Tuberculosis VaccinesIBA 03/2024
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 02/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Immunoglobulins (Immunoglobulin)IBA 12/2021
1	Chloride Channels (Chloride Channel)IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Histones (Histone)IBA 10/2020
1	GlutaminaseIBA 10/2020
1	Peptide Hydrolases (Proteases)FDA Link 10/2020
1	PerforinIBA 01/2020
1	Imiquimod (Aldara)FDA LinkGeneric 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	TubulinIBA 11/2019
1	SeleniumIBA 11/2019
1	malic acid (malate)IBA 09/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2019
1	SolutionsIBA 09/2019
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 08/2019
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2017
1	Sirolimus (Rapamycin)FDA Link 11/2016
1	Transcription Factors (Transcription Factor)IBA 06/2014
1	cholanthreneIBA 07/2013
1	Interleukin-12 (IL 12)IBA 07/2013
1	Interleukin-27 (Interleukin 27)IBA 07/2013
1	flurbiprofen axetilIBA 02/2013
1	Flurbiprofen (Froben)FDA LinkGeneric 02/2013
1	Morphine (MS Contin)FDA LinkGeneric 02/2013
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012
1	Therapeutic UsesIBA 09/2012
1	NK-007IBA 09/2012
1	Interleukin-4 (Interleukin 4)IBA 11/2011
1	Collagen Type II (Type II Collagen)IBA 01/2011
1	Interleukin-10 (Interleukin 10)IBA 01/2011
1	Interleukin-10 ReceptorsIBA 01/2011
1	InterferonsIBA 11/2010

Therapy/Procedure

6	Immunotherapy 01/2023 - 11/2010
5	Therapeutics 01/2021 - 07/2010
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2019